Merck Proposes 27,000-Patient Observational Trial As Follow-up for Male Use of Gardasil

Extension of vaccine to 9-15 year-old boys to prevent genital warts receives lopsided FDA advisory committee votes but some questions about postmarketing studies and duration of effect.